Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 1;18(6):4625–4630. doi: 10.3892/etm.2019.8163

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019, Spandidos Publications

PMC Copyright notice

Figure 2. — Effects of dTACE on HCC. (A) HCC lesion (indicated by red arrows) located in the right hepatic lobe as observed using artery enhancement MR scanning. (B) HCC lesion (indicated by red arrows) was clearly observed using venous enhancement MR scanning; (C) digital subtraction angiography of HCC lesion (indicated by red arrows) during dTACE; (D) Complete tumor response 2 years later in artery enhancement and (E) venous enhancement MR scanning follow-up. dTACE, drug-eluting bead transarterial chemoembolization; HCC, hepatocellular carcinoma. MR, Magnetic Resonance.